Feed KRO
KR

Kronos

KRO · NYSE

$7.84 -0.25% (-$0.02)
1M -8.92%
Market Cap $904.3M
P/E Ratio -
Div. Yield 2.54%
ROE 14.34%

Bulios Fair Price

$6.59

15.9% downside

Current Price

$7.84

Undervalued Fair Value Overvalued

According to Bulios Fair Price, KRO is currently overvalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
5/9
Valuation
59 /100
Fair
EV/EBITDA 133.30x
P/S 0.47x
P/FCF 13.30x
Growth
25 /100
Declining
Rev. growth 1.24%
Book val. growth 7.76%
EPS growth N/A
Profitability
20 /100
Weak
Gross margin 11.81%
Net margin 5.63%
FCF margin 3.50%
Quality
15 /100
Poor
ROIC 2.09%
ROE 14.34%
Asset turnover 1.11x
Debt
38 /100
Moderate
Debt/Equity 0.78x
Current ratio 3.30x
Net debt/EBITDA 51.09x
Stability
57 /100
Moderate
Beta 1.06x
Rev. volatility 13.47%
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about KRO
Online

About the company

Kronos Worldwide, Inc. is an American chemical company focused on the production and sale of titanium dioxide, used in various industrial applications such as paints, coatings, plastics, and paper. The company emphasizes sustainability, production efficiency, and minimizing the environmental impact of its manufacturing operations.

Sector

Basic Materials

Industry

Chemicals - Specialty

CEO

Brian W. Christian

Employees

2,263

Headquarters

Dallas

Upcoming events

05 NOV

Earnings

Upcoming earnings report

29d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.